[HTML][HTML] Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2 …
D Li, W Wang, B Liu, D Jin, Y Wang, G He, L Guo… - Cell Death …, 2023 - nature.com
Abstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2 …
D Li, W Wang, B Liu, D Jin, Y Wang, G He… - Cell Death …, 2023 - search.ebscohost.com
Abstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
[HTML][HTML] Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2 …
D Li, W Wang, B Liu, D Jin, Y Wang, G He… - Cell Death …, 2023 - ncbi.nlm.nih.gov
Abstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2 …
D Li, W Wang, B Liu, D Jin, Y Wang, G He… - Cell Death …, 2023 - search.proquest.com
Abstract Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2 …
D Li, W Wang, B Liu, D Jin, Y Wang… - Cell death …, 2023 - pubmed.ncbi.nlm.nih.gov
Iodine-125 (I-125) radioactive seed implantation is used for the local treatment of
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
hepatocellular carcinoma (HCC), but the molecular mechanisms regulating its anticancer …
Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2 …
D Li, W Wang, B Liu, D Jin, Y Wang, G He… - Cell Death …, 2023 - europepmc.org
Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced
anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis. - Abstract …
anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis. - Abstract …
[引用][C] Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2 …
D Li, W Wang, B Liu, D Jin, Y Wang, G He, L Guo… - 2023 - europepmc.org
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths in
China [1]. Approximately 400,000 people die from liver cancer every year [2]. Approximately …
China [1]. Approximately 400,000 people die from liver cancer every year [2]. Approximately …